Gene · 8880
Papers1,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| VILMIR is a trans-acting long noncoding RNA that enhances the host interferon response in human epithelial cells. | J Virol | 2026 | 41378895 | PubTator, text mining | PubMed |
| The Impact of the FXR1-FUBP1 Axis on Chemotherapy Resistance in LUSC Cells. | Biochem Genet | 2026 | 41273664 | PubTator, text mining | PubMed |
| Expression of Far Upstream Element-Binding Protein in Gastrointestinal Stromal Tumors and Its Regulation of Cell Proliferation, Migration, and Invasion. | Pathobiology | 2026 | 40875732 | PubTator, text mining | PubMed |
| Diagnostic Biomarkers and Targeted Drug Prediction for Acute Kidney Injury: A Computational Approach | Endocr Metab Immune Disord Drug Targets | 2026 | 40754871 | PubTator, text mining | PubMed |
| Quantitative Reactivity Profiling of Functional Arginine Residues in Human Cancer Cell Line Proteomes. | Angew Chem Int Ed Engl | 2025 | 41116259 | PubTator, text mining | PubMed |
| Nuclear 2'-O-methylation regulates RNA splicing through its binding protein FUBP1. | Sci Adv | 2025 | 41105785 | PubTator, text mining | PubMed |
| Research advancements regarding the relationship between FBXO2 and malignant tumors (Review). | Mol Med Rep | 2025 | 40999994 | PubTator, text mining | PubMed |
| PTBP1 Reduces KLF9 mRNA Stability and Upregulates FUBP1 to Promote Colorectal Cancer Stemness and Cisplatin Resistance. | FASEB J | 2025 | 40965935 | PubTator, text mining | PubMed |
| Identification of lactylation-related biomarkers in osteoporosis from transcriptome and single-cell data. | Front Endocrinol (Lausanne) | 2025 | 40927289 | PubTator, text mining | PubMed |
| ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas. | NPJ Precis Oncol | 2025 | 40866630 | PubTator, text mining | PubMed |
| The regulation of miR-155 strand selection by CELF2, FUBP1 and KSRP proteins. | Sci Rep | 2025 | 40825800 | PubTator, text mining | PubMed |
| Regulatory roles of circular RNAs in Wnt and other oncogenic signaling pathways in breast cancer progression: a comprehensive review. | Eur J Med Res | 2025 | 40804731 | PubTator, text mining | PubMed |
| Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid-resistant immune thrombocytopenia. | Br J Haematol | 2025 | 40781812 | PubTator, text mining | PubMed |
| Integrative analysis of polyamine metabolism-related genes in gliomas: implications for prognosis and therapy. | Front Oncol | 2025 | 40761256 | PubTator, text mining | PubMed |
| Epigenetic Activation of CCDC183-AS1 Promotes Osteoclastogenesis and Prostate Cancer Bone Metastasis Through the FUBP1/LIGHT Axis. | Adv Sci (Weinh) | 2025 | 40685790 | PubTator, text mining | PubMed |
| Mapping the immune-genetic architecture of aging: A single-cell causal framework for biomarker discovery and therapeutic targeting. | Ageing Res Rev | 2025 | 40659289 | PubTator, text mining | PubMed |
| circACTN4 promotes breast cancer cell cycle progression and oncogenesis via c-MYC induced histone H4 acetylation. | Oncol Res | 2025 | 40612865 | PubTator, text mining | PubMed |
| Regulatory RNA network mediated by FUBP1 drives the proliferation and invasion of triple-negative breast cancer cells. | Med Oncol | 2025 | 40580249 | PubTator, text mining | PubMed |
| Disruption of Microhomology-mediated End-joining in Ewing Sarcoma. | bioRxiv | 2025 | 40568108 | PubTator, text mining | PubMed |
| Identification of Proteins Associated with Ovarian Cancer Chemotherapy Resistance Using MALDI-MSI. | Int J Mol Sci | 2025 | 40565351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8880/papers?page=2